I agree with Natarajan and Ravikumar that overseas doctors have been treated very shabbily. 1 One of the surprising features of the whole affair has been the lack of outcry from UK and EU doctors in protest. The British Medical Association's response has been muted to say the least. But is this so surprising? In medicine, as in life, there are winners as well as losers and the simple truth is that UK and EU doctors are the winners here. Their jobs will be protected. They will not have to prove that they are better than overseas doctors to get a job; they will merely have to be available and be able to do the job. 2 But UK and EU doctors should not become too smug. It is likely that, over the coming years, the large increase in the number of UK medical graduates will make medical unemployment a reality in this country. 3 What will they do then? They could go abroad; but in light of the UK's treatment of overseas doctors they should not count on too warm a welcome. Who will speak up for them? We would do well to remember the words of Martin Niemoller, a German pastor: 'First they came for the Jews and I did not speak out-because I was not a Jew. Then they came for the communists and I did not speak out-because I was not a communist. Then they came for the trade unionists and I did not speak out-because I was not a trade unionist. Then they came for me-and there was no one left to speak out for me'.
Competing interests None declared. Although this may be partly true, it is important to mention that our classifications change with emerging novel evidence. In fact, the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project has been set up to address nosological issues and improve the clinical utility of the concept of major depressive disorder (MDD). 2 Also, a long-term prospective, naturalistic study of depressive symptoms in MDD showed a generally fluctuating mood state with minor and subsyndromal levels alternating with the MDD syndrome in the same patients, suggestive of an illness on a continuum. 3 Furthermore, a recent well-conducted placebo-controlled study has shown fluoxetine to have efficacy in the treatment of minor depression. 4 One must not ignore the role of culture and the individual patient's narrative. However, neither can we ignore the evidence for the role of biology in depression, in particular the efficacy of antidepressants in relapse prevention. 5 
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